Lijun Wang, Dongmei Li, Jie Wang, Y. Jing, Zhongmei Wang, Yanjun Jia
{"title":"HLA-A, -B, -C, -DRB1 and -DQB1 alleles associated with different hematological diseases in Chinese population","authors":"Lijun Wang, Dongmei Li, Jie Wang, Y. Jing, Zhongmei Wang, Yanjun Jia","doi":"10.46701/bg.2021022021116","DOIUrl":"https://doi.org/10.46701/bg.2021022021116","url":null,"abstract":"","PeriodicalId":87226,"journal":{"name":"Blood and genomics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70577679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The combination of DNA methyltransferase inhibitor therapy and immunotherapy for acute myeloid leukemia","authors":"Yuxuan Wu, Z. Xiang","doi":"10.46701/bg.2021022021132","DOIUrl":"https://doi.org/10.46701/bg.2021022021132","url":null,"abstract":"","PeriodicalId":87226,"journal":{"name":"Blood and genomics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70577872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The progress and perspectives of CAR-T cell therapy","authors":"Yan Peng, Zhenqing Feng","doi":"10.46701/bg.2021022021126","DOIUrl":"https://doi.org/10.46701/bg.2021022021126","url":null,"abstract":"","PeriodicalId":87226,"journal":{"name":"Blood and genomics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70577641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Identification and analysis of a rare CisAB group","authors":"Ziyi He, Ying-xin Hu, Si-Xing Cui","doi":"10.46701/bg.2020012019133","DOIUrl":"https://doi.org/10.46701/bg.2020012019133","url":null,"abstract":"Incompatible ABO transfusion can lead to immune hemolytic transfusion reaction. Accordingly, a correct ABO subgroup identification is vital for blood transfusion safety. ABO subgroups are often characterized by their abnormal appearances and a weakening or disappearance of antigens or antibodies, resulting in mismatched forward and reverse typing. This is mainly caused by ABO gene mutations, leading to a decrease in A/B transferase activity. This makes ABO subgroups prone to misidentification, which has an important impact on the safety and efficacy of transfusion. The CisAB group is one of such ABO subgroups with a complex phenotype, which due to various factors is difficult to determine using routine serological testing. Here, one CisAB group case in the Dongguan Blood Center was identified and reported as follows.","PeriodicalId":87226,"journal":{"name":"Blood and genomics","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80921157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Genetic predisposition to multiple myeloma","authors":"Yan Cheng, Fumou Sun, X. Cui, S. Janz","doi":"10.46701/bg.2020012020103","DOIUrl":"https://doi.org/10.46701/bg.2020012020103","url":null,"abstract":"Genetic myeloma risk research relied on genome - wide association studies to identify 24 common but low-impact germline predisposition alleles that account for an estimated one eighth of the heritable myeloma risk in Caucasians. Next - generation sequencing, particularly whole - exome sequencing, uncovered a handful of rare but high - impact myeloma risk loci that convey intriguing clues about etiology. The recent discovery of NCOA1 as a myeloma susceptibility gene in Han Chinese has set the stage for the more complete elucidation of the genetic myeloma risk across ethnic barriers. Validating individual myeloma risk loci at the functional level and integrat-ing predisposition genes in genetic networks and biological pathways are important research tasks going forward. Candidate pathways that are currently emerging include plasma cell development, autophagy, telomere maintenance, and cell cycle regulation. An outstanding knowledge gap in the area of gene - environment interaction con-cerns the possibility that tumor - promoting effects of myeloma susceptibility alleles depend on specific environmental or occupational exposures. An implicit promise of myeloma risk research is the detection of new molecular targets for myeloma treatments and preventions. A related outcome is new biomarkers for patient stratification, prognostication, and development of individualized treatment plans.","PeriodicalId":87226,"journal":{"name":"Blood and genomics","volume":"111 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89318216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Serological and genetic analysis of ABO ambiguous blood group samples","authors":"Ying Li, Jinming Xu, Yongliang Zhu, Ting Xiong, Ling Zhao, Yunnan Yao, Xiaoyu Zhou","doi":"10.46701/bg.2020022020112","DOIUrl":"https://doi.org/10.46701/bg.2020022020112","url":null,"abstract":"The accuracy of regular serum methods to detect ABO blood groups can be negatively affected by some factors, such as irregular antibodies, autoantibodies or effects of diseases leading to false or weak agglutination. This study aimed to accurately identify ambiguous ABO blood groups by serological and gene detection methods. The samples were collected in the First Affiliated Hospital of Nanjing Medical University from December 2018 to December 2019. ABO genotyping was performed by polymerase chain reaction-sequence specific primer (PCR-SSP) method in 20 samples, and ABO exons 6 and 7 or FUT1 and FUT2 genes were sequenced in 5 samples. The genes detected in the 21 specimens included 4 cases of A/B, 2 cases of A205/O01, 3 cases of A/O01, 3 cases of A/O02, 1 case of O01/O01, 1 case of O01/O02, 1 case of B/O01, 1 case of B/O02, 1 case of Bel/O01, 1 case of Cisab01/O01, 1 case of rare B/O04, 1 case of Bombay-like Bmh, 1 case of new gene showing c.261del G of exon 6, c.579 T>C of exon 7 and B new/O01. This study suggests that ABO blood group genotyping technology combined with serological typing can be used for accurately typing ambiguous blood groups.","PeriodicalId":87226,"journal":{"name":"Blood and genomics","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83050004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jie Wang, lin gui, Wei-xin Zhou, Jianbo Yang, Yuanshuai Huang
{"title":"Rare B(A)02/O01 was found in Sichuan again: a case report","authors":"Jie Wang, lin gui, Wei-xin Zhou, Jianbo Yang, Yuanshuai Huang","doi":"10.46701/bg.2020022020117","DOIUrl":"https://doi.org/10.46701/bg.2020022020117","url":null,"abstract":"B(A) is a rare ABO blood subgroup. Here we reported a B(A)02/O01 case. One 25-year-old female patient showed inconsistent forward and reverse blood grouping results based on micro-column gel agglutination assay. PCR-SSP and PCR-SBT based genotyping indicated that the patient was B(A)02/O01 heterozygous.","PeriodicalId":87226,"journal":{"name":"Blood and genomics","volume":"109 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88790182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Samy M Attallah, Tarek Hakeem, Ebrahim Hamdy, Zyiad AlHarby, Faisal Althubiani, Ershad Dade, Abdulla Al Harbi
{"title":"Prevalence and specificity of some rare red cell pan-reactive alloantibodies against high frequency red cell antigens among hospitalized Saudi patients","authors":"Samy M Attallah, Tarek Hakeem, Ebrahim Hamdy, Zyiad AlHarby, Faisal Althubiani, Ershad Dade, Abdulla Al Harbi","doi":"10.46701/bg.2020022020126","DOIUrl":"https://doi.org/10.46701/bg.2020022020126","url":null,"abstract":"Some patients' sera react with all available donors' red cells and a compatible donor is difficult or impossible to be found. These may either be due to a complex mixture of antibodies or the presence of alloantibodies against high-frequency antigens (HFAs). The aim of this study is to identify the prevalence and characteristics of antibodies to HFAs in Saudi Arabian patients. A total of 23 out of 172 000 patients who received blood transfusions had rare alloantibodies to HFAs at an incidence of 0.013%. Twenty-three patients suspected with pan-reactive alloantibodies against HFAs had their red cells tested using antisera to HFAs, while their plasma was tested against a selected panel of red blood cells with rare phenotypes. Anti-Ge2 antibody was found in the highest number of patients (56.5%), whereas anti-U, anti JK3, anti H, anti-RH 29, anti-hr, anti-Kn, anti-Ch, anti-Rg, anti-Yt, and anti-Cr antibodies were found in the remaining patients (43.5%). This study suggests that although antibodies such as anti-Ge2, antiKn, anti-Ch, anti-Rg, anti-Yt , and anti-Cr are not clinically significant, they cause a delay in the provision of compatible blood. Whereas, anti-U, anti JK3, anti H, anti-RH29 and anti-hr are clinically significant antibodies. An understanding of antibody characteristics to HFAs and the widespread use of the extended red cell phenotype and antibody identification panel will both be helpful for the diagnosis of these HFAs.","PeriodicalId":87226,"journal":{"name":"Blood and genomics","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84463599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Coronavirus disease 2019 (COVID-19): diagnosis and prognosis.","authors":"Xueying Wang, Yang Zhou, Linlin Liu, Jinmin Ma, Honglong Wu, Lijian Zhao, Weijun Chen, Shengwen Calvin Li, Qian Ran, Zhongjun Li","doi":"10.46701/BG.2020022020120","DOIUrl":"10.46701/BG.2020022020120","url":null,"abstract":"<p><p>Coronavirus disease 2019 (COVID-19) has become a global pandemic with a high rate of transmission. Currently, there is a lack of vaccines and specific drugs for this newly-emerged virus. Timely diagnosis and treatment, as well as isolation of patients and virus carriers, contribute to the effective prevention and control of this epidemic. This review focuses on early stage COVID-19 diagnosis methods and strategies, highlighting the guiding role of laboratory indicators on treatment strategy formulation, and prognosis assessments.</p>","PeriodicalId":87226,"journal":{"name":"Blood and genomics","volume":"4 2","pages":"96-107"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990318/pdf/nihms-1678215.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25517675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"B para-Bombay phenotype in China caused by homozygous mutation for site 328 G>A of FUT1 gene: a case report","authors":"Z. Gu, Chun Li, Hua-Dong Lu","doi":"10.46701/bg.2020022020116","DOIUrl":"https://doi.org/10.46701/bg.2020022020116","url":null,"abstract":"The aim of this paper is to accurately identify a case of B para-Bombay and to analyze the genetic mutation. ABO and Lewis blood groups were identified by standard serological methods, and trace antigens on RBCs were detected by adsorption-elution test, while blood group substances in the saliva were detected by agglutination inhibition test. The ABO gene exons 6-7, FUT1 gene exon 4 and FUT2 gene exon 2 were directly sequenced. Serological results showed that there were B antigens on RBCs without H antigens, anti-A and anti-HI antibodies in serum, and B and H blood group substances in the saliva. The Lewis phenotype was Le (a-b+). According to gene sequencing analysis, ABO, FUT1 and FUT2 genotypes were B101/O02, h 328G/A h 328G/A and Se 357C/T Se 357C/T , respectively. This rare phenotype can be mislabeled as \"O\" if any of the detailed investigations are not performed. Therefore, in order to ensure the safety of blood transfusion, genetic and serological tests are necessary for the correct identification of difficult blood groups.","PeriodicalId":87226,"journal":{"name":"Blood and genomics","volume":"189 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77372599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}